Felipe Fumagallo Reading is a postdoctoral researcher at the Faculty of Health Sciences in the University of La Laguna and the research unit of the Canary Islands University Hospital. Felipe obtained a degree in Biology in 2012 and his PhD in Health Sciences in 2021, both at the University of La Laguna. Felipe has obtained predoctoral and postdoctoral working fellowships with public and private fundings covering 10 years as a professional researcher. His field of research is neuroscience, including neurodegenerative murine and cell models obtained from genetic engineering, and which have resulted in several research papers. Felipe is currently studying dopaminergic receptor pathways in Parkinson's and Huntington's disease for drug therapy, and also the biology of the TARDBP/Tardbp gene and its encoded protein TDP-43 affected in Amyotrophic Lateral Sclerosis (ALS) disease. He is also focused in teaching at the anatomy department of the University of La Laguna. Felipe is a member of the ITB (Biomedical research institute in Tenerife).